To the best of our knowledge, this is the first study evaluating the anti-cancer effect of NTP on cell migration and invasion associated with cytoskeletal modulation and changes of matrix metalloproteinase (MMP)-2/-9/urokinase-type plasminogen activator (uPA) activities. The gene discussed is PLAU; the disease is cancer.